Browse > Article
http://dx.doi.org/10.3904/kjim.2016.253

Current status of managing diabetes mellitus in Korea  

Ha, Kyoung Hwa (Department of Endocrinology and Metabolism, Ajou University School of Medicine)
Kim, Dae Jung (Department of Endocrinology and Metabolism, Ajou University School of Medicine)
Publication Information
The Korean journal of internal medicine / v.31, no.5, 2016 , pp. 845-850 More about this Journal
Abstract
Diabetes mellitus is an increasing global health problem. Guidelines for diabetic care recommend management of lifestyle and risk factors (glucose, blood pressure, and cholesterol), as well as regular screening for complications associated with treatment of the conditions related to diabetes. The prevalence of diabetes increased from 8.6% to 11.0% from 2001 to 2013. According to the diabetes fact sheet 2015, the proportion of patients with diabetes treated with antihypertensive medications increased from 56.0% to 62.5% from 2006 to 2013, and 49.5% of those with diabetes were being treated with lipid-lowering medications in 2013, a 1.8-fold increase since 2006. According to the 2014 Korea National Health and Nutrition Examination Survey data, 45.6% of patients with diabetes achieved a hemoglobin A1c level of < 7.0%, 72.8% achieved a blood pressure of < 140/85 mmHg, and 58.0% achieved a low density lipoprotein cholesterol level of < 100 mg/dL. Only 19.7% of patients with diabetes had good control of all three of these parameters. Despite improvements in health promotion efforts, the rates of adherence to medication and risk-factor control are low. Therefore, a systematic approach to managing diabetes, including self-management education, is needed to prevent or delay complications. The government needs to establish a long-term policy to address the growing burden of diabetes.
Keywords
Diabetes mellitus; Diabetes management; Korea;
Citations & Related Records
Times Cited By KSCI : 8  (Citation Analysis)
연도 인용수 순위
1 Alva ML, Gray A, Mihaylova B, Leal J, Holman RR. The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84). Diabet Med 2015;32:459-466.   DOI
2 Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.   DOI
3 Ha KH, Kim DJ. Trends in the diabetes epidemic in Korea. Endocrinol Metab (Seoul) 2015;30:142-146.   DOI
4 Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus of Korean Diabetes Association, Park Ie B, Kim J, et al. Diabetes epidemics in Korea: reappraise nationwide survey of diabetes "diabetes in Korea 2007". Diabetes Metab J 2013;37:233-239.   DOI
5 Song SO, Lee YH, Kim DW, et al. Trends in diabetes incidence in the last decade based on Korean National Health Insurance claims data. Endocrinol Metab (Seoul) 2016;31:292-299.   DOI
6 Al-Saeed AH, Constantino MI, Molyneaux L, et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care 2016;39:823-829.   DOI
7 Berkowitz SA, Meigs JB, Wexler DJ. Age at type 2 diabetes onset and glycaemic control: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2010. Diabetologia 2013;56:2593-2600.   DOI
8 Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care 2008;31:1985-1990.   DOI
9 Korean Diabetes Association. Korean diabetes fact sheet 2015 [Internet]. Seoul (KR): Korean Diabetes Association; c2011 [cited 2016 Aug 18]. Available from: http://www.diabetes.or.kr/.
10 Ko SH, Kim DJ, Park JH, et al. Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: nationwide population-based cohort study. Medicine (Baltimore) 2016;95:e4018.   DOI
11 Kim HJ, Kim YG, Park JS, Ahn YH, Ha KH, Kim DJ. Association between blood glucose level derived using the oral glucose tolerance test and glycated hemoglobin level. Korean J Intern Med 2016;31:535-542.   DOI
12 Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013;93:137-188.   DOI
13 Nathan DM; DCCT/EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 2014;37:9-16.   DOI
14 Zoungas S, Woodward M, Li Q, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia 2014;57:2465-2474.   DOI
15 Rhee SY, Chon S, Kwon MK, et al. Prevalence of chronic complications in Korean patients with type 2 diabetes mellitus based on the Korean National Diabetes Program. Diabetes Metab J 2011;35:504-512.   DOI
16 Lee WJ, Sobrin L, Lee MJ, Kang MH, Seong M, Cho H. The relationship between diabetic retinopathy and diabetic nephropathy in a population-based study in Korea (KNHANES V-2, 3). Invest Ophthalmol Vis Sci 2014;55:6547-6553.   DOI
17 Won JC, Kwon HS, Kim CH, et al. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with type 2 diabetes in Korea. Diabet Med 2012;29:e290-e296.   DOI
18 Jin DC. Major changes and improvements of dialysis therapy in Korea: review of end-stage renal disease registry. Korean J Intern Med 2015;30:17-22.   DOI
19 Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753-759.   DOI
20 Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279-2290.   DOI
21 Ylitalo KR, Sowers M, Heeringa S. Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2011;34:1642-1647.   DOI
22 Jeon JY, Kim DJ, Ko SH, et al. Current status of glycemic control of patients with diabetes in Korea: the fifth Korea National Health and Nutrition Examination Survey. Diabetes Metab J 2014;38:197-203.   DOI
23 American Diabetes Association. 6. Obesity management for the treatment of type 2 diabetes. Diabetes Care 2016;39 Suppl 1:S47-S51.   DOI
24 American Diabetes Association. 8. Cardiovascular disease and risk management. Diabetes Care 2016;39 Suppl 1:S60-S71.   DOI
25 Son JW, Park CY, Kim S, Lee HK, Lee YS; Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug Naive Type 2 Diabetes Patients in Korea (SURPRISE) Study Group. Changing clinical characteristics according to insulin resistance and insulin secretion in newly diagnosed type 2 diabetic patients in Korea. Diabetes Metab J 2015;39:387-394.   DOI
26 Ko KS, Oh TG, Kim CH, et al. A clinical study on the complications of non-insulin-dependent diabetes mellitus in Korea. J Korean Diabetes Assoc 1991;15:257-262.
27 Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011;35:303-308.   DOI
28 Shi Y, Hu FB. The global implications of diabetes and cancer. Lancet 2014;383:1947-1948.   DOI
29 Koo BK, Lee CH, Yang BR, Hwang SS, Choi NK. The incidence and prevalence of diabetes mellitus and related atherosclerotic complications in Korea: a National Health Insurance Database Study. PLoS One 2014;9:e110650.   DOI
30 Byun SH, Ma SH, Jun JK, Jung KW, Park B. Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea. PLoS One 2013;8:e62991.   DOI
31 UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.   DOI
32 Chung JH, Moon K, Kim do H, Min JW, Kim TH, Hwang HJ. Suicidal ideation and suicide attempts among diabetes mellitus: the Korea National Health and Nutrition Examination Survey (KNHANES IV, V) from 2007 to 2012. J Psychosom Res 2014;77:457-461.   DOI
33 Han SJ, Kim HJ, Choi YJ, Lee KW, Kim DJ. Increased risk of suicidal ideation in Korean adults with both diabetes and depression. Diabetes Res Clin Pract 2013;101:e14-e17.   DOI
34 Lee YJ, Kang HM, Kim NK, et al. Factors associated for mild cognitive impairment in older Korean adults with type 2 diabetes mellitus. Diabetes Metab J 2014;38:150-157.   DOI
35 Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-149.   DOI
36 Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177-188.   DOI
37 The Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995;75:894-903.   DOI
38 UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713.   DOI
39 Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393.   DOI
40 Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 2014;370:1514-1523.   DOI
41 Korean Diabetes Association. Treatment guideline for diabetes 2015 [Internet]. Seoul (KR): Korean Diabetes Association, c2011 [cited 2016 Aug 18]. Available from: http://www.diabetes.or.kr/.
42 Sabate E. Adherence to long-term therapies: evidence for action [Internet]. Geneva (CH): World Health Organization, c2016 [cited 2016 Aug 18]. Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/.
43 Garcia-Perez LE, Alvarez M, Dilla T, Gil-Guillen V, Orozco-Beltran D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther 2013;4:175-194.   DOI
44 Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128.   DOI
45 American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-1046.   DOI